News ArchivesRead News

Treadmill Training Improves Walking in Parkinson's

Thursday January 21, 2010

Michael Smith

MedPage Today - Treadmill training can improve the impaired walking associated with Parkinson's disease, researchers said.

The technique leads to improvements in gait speed, stride length, and walking distance, but not gait cadence, according to Jan Mehrholz, PhD, of the Klinik Bavaria in Kreischa, Germany, and colleagues.

However, it remains unclear how long such improvements last, the researchers noted in a Cochrane Systematic Review.

Treadmill training has emerged recently as a "promising investigational therapy" aimed at patients with weakness on one side of the body and impaired gait, Mehrholz and colleagues wrote in their review.

To evaluate what's known about the subject, the researchers searched the literature and found eight randomized, controlled studies with a total of 203 participants.
On average, patients were 61, with an average duration of disease in the studies ranging from one to eight years.

When the studies were analyzed, the researchers found:

Seven studies -- with153 participants all told -- found
that treadmill training improved gait speed. The pooled
standardized mean difference was 0.50, which was
significant at P=0.003.

Five studies, with a total of 95 participants, looked at
stride length and found that treadmill training was
beneficial. The pooled standardized mean difference was
0.50, which was significant at P=0.05.

Two studies, with 41 participants, found that treadmill
training improved walking distance. The mean difference
was 358 meters, which was significant at P<0.0001.

Finally, four studies (with 78 participants) found no
significant mean difference in cadence.

The treadmill training was acceptable to patients, the researchers said, in that it did not increase the risk of patients dropping out of studies. Adverse events were not reported.

The researchers noted that the study protocols varied markedly.

The treadmill training lasted from one 30-minute session to eight weeks, although most studies used a four-, six- or eight-week period. Frequency varied from a single session to four times a week, the researchers said.

The type of treadmill training also varied, with some investigators using body-weight supported treadmill training and others a speed-dependent approach.

Primary outcomes also differed, Mehrholz and colleagues said.

Because of those variations, they said, there is "still a need for well-designed large-scale studies" to look at the risk and benefits of treadmill training for Parkinson's patients.

Specifically, they said, those studies should address open questions about how long the effect lasts and what should be the frequency and duration of training.

The study was supported by the Klinik Bavaria Kreischa, the Technical University Dresden, SRH Fachhochschule Gera, and the California State University Long Beach.

Mehrholz and another author were co-authors of one included trial but did not participate in its quality assessment and data extraction.

Recent News

Oct 18 - Fighting Parkinson's disease through dance
Oct 18 - Brain disconnections may contribute to Parkinson's hallucinations
Oct 17 - Scientists Identify Structure of PINK1, Key Parkinson’s-protective Protein
Oct 17 - Diabetes drug cuts Parkinson's risk by 28 percent, study finds
Oct 10 - Advances in Brain Pacemaker Reduces Tremors, Helps Parkinson's Sufferers Live a More Normal Life
Oct 10 - Medical History Could Help Predict Parkinson's Disease Risk Long Before Diagnosis
Oct 3 - Changes in Olfactory Bulb Explain Loss of Smell in Early Stages of Parkinson’s Disease, Study Finds
Oct 3 - Sleep Disturbances May Worsen Motor Symptoms in Parkinson’s Disease, Study Suggests
Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show